share_log

Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%), etc.

SEC announcement ·  Feb 12 09:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more